Changchun BCHT Biotechnology Co. A

SHG:688276 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.06 Billion
CN¥7.78 Billion CNY
Market Cap Rank
#12973 Global
#3279 in China
Share Price
CN¥18.81
Change (1 day)
-0.58%
52-Week Range
CN¥18.53 - CN¥25.44
All Time High
CN¥117.52
About

Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally. The company's products include herpes zoster vaccine; varicella vaccine; live, nasal, and freeze-dried influenza vaccine; and rabies vaccine (vero cell) for humans. Changchun BCHT Biotechnology Co. Ltd. was founded in 200… Read more

Changchun BCHT Biotechnology Co. A (688276) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: -0.006x

Based on the latest financial reports, Changchun BCHT Biotechnology Co. A (688276) has a cash flow conversion efficiency ratio of -0.006x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-22.21 Million) by net assets (CN¥3.96 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Changchun BCHT Biotechnology Co. A - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Changchun BCHT Biotechnology Co. A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Changchun BCHT Biotechnology Co. A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Changchun BCHT Biotechnology Co. A ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Changchun BCHT Biotechnology Co. A (2017–2024)

The table below shows the annual cash flow conversion efficiency of Changchun BCHT Biotechnology Co. A from 2017 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥4.22 Billion CN¥406.50 Million 0.096x +51.83%
2023-12-31 CN¥4.02 Billion CN¥255.21 Million 0.063x +467.46%
2022-12-31 CN¥3.56 Billion CN¥39.82 Million 0.011x -72.75%
2021-12-31 CN¥3.42 Billion CN¥140.30 Million 0.041x -65.06%
2020-12-31 CN¥1.78 Billion CN¥209.16 Million 0.118x -48.86%
2019-12-31 CN¥1.01 Billion CN¥232.80 Million 0.230x -31.90%
2018-12-31 CN¥799.55 Million CN¥269.79 Million 0.337x +14.45%
2017-12-31 CN¥600.51 Million CN¥177.05 Million 0.295x --